Replies to post #189869 on Cytodyn Inc (CYDY)

[misiu143]

Ok , no P-value .
I guess just approved Biogen drug for Alz.
WITH ...
--no clinical significance,
--no endpoints
--no p-value,
Up to 30% developing severe side effects like brain edema and bleeding..

This showed us that things like p-value are no longer needed for approval .

So leronlimab should be approved long time go , especially that IT IS saving lives , I saw that first hand with my family...

GLTU.

imo.

[Itchy palm]

The only flaw is trusting the American FDA to allow the best drug for are people

[bwolfy2002]

It’s not flawed. I know that LL works when it is in the body to work. Period. It’s proving it beyond deniability to the folks that give approval that stands in the way. And that we’re working on. No one time trade gets in the way of that mission and end game.

IMOP